95 results
Page 4 of 5
8-K
EX-99.1
w5i3hu73pj81
2 Jul 21
InMed Pharmaceuticals Announces Closing of US$12 Million Private Placement
4:27pm
8-K
EX-99.1
1jwows6gwd788y
30 Jun 21
InMed Pharmaceuticals Announces $12 Million Private Placement
12:00am
8-K
EX-99.1
775ed c48zz
29 Jun 21
InMed Pharmaceuticals Signs Non-binding Letter of Intent to Acquire BayMedica, a Commercial Manufacturer of Rare Cannabinoids
3:12pm
8-K
EX-99.1
isqlc1
23 Jun 21
Regulation FD Disclosure
12:00am
8-K
EX-99.1
69pyp4a
17 Jun 21
Regulation FD Disclosure
1:19pm
8-K
EX-99.1
jnt6psgbdbp478bmbptd
13 May 21
InMed Pharmaceuticals Reports Third Quarter Fiscal 2021 Financial Results
4:23pm
8-K
EX-99.1
skxx7 umravp3
28 Apr 21
Regulation FD Disclosure
1:31pm
8-K
EX-99.1
tzaq0f 08t
27 Apr 21
Regulation FD Disclosure
4:22pm
8-K
EX-99.2
4qw7kqqa
27 Apr 21
Regulation FD Disclosure
4:22pm
424B3
jqiv npasa0
16 Mar 21
Prospectus supplement
12:00am
8-K
EX-99.1
5q1vedtbv y4zu1
16 Feb 21
InMed Announces Closing of US$4.5 Million Private Placement
6:12am
8-K
EX-99.1
slbc7l8jllprr91lk3
12 Feb 21
InMed Pharmaceuticals Reports Second Quarter Fiscal 2021 Financial Results
12:35pm
8-K
EX-99.1
edu2z37ih6
5 Feb 21
InMed Announces US$4.5 Million Private Placement
5:28pm
8-K
EX-99.1
sqzwr8qr83l2lf 5n9pb
20 Jan 21
Regulation FD Disclosure
3:43pm
8-K
EX-99.1
viy7r8x kepu6dpw6hej
8 Jan 21
InMed Announces Results of Second Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
10:53am
10-Q
9i8uwectfps klwuy5
17 Dec 20
Quarterly report
12:00am
8-K
EX-99.1
9uuf6r1ucq63
3 Dec 20
Regulation FD Disclosure
12:59pm
8-K
EX-99.1
0984bujb
25 Nov 20
InMed Announces Results of Initial Phase 1 Clinical Trial of INM-755
10:47am